<unk><unk> -resistant TB (MDR-TB) is caused by Mycobacterium tuberculosis that is resistant to at least isoniazid and rifampin, the two most potent TB<unk> s. Anti-tuberculosis (TB)<unk>  resistance is a major public health problem that threatens the progress made in TB care and control worldwide.<unk>  resistance arises due to improper use of antibiotics in chemotherapy of<unk> -susceptible TB patients. This improper use is a result of a number of actions including, administration of inadequate treatment regimens and failure to ensure that patients complete the whole course of treatment. Essentially,<unk>  resistance arises particularly in areas with weak TB control programmes. Symptoms may include fever, weight loss, night sweats and cough. Diagnosis of MDR-TB can be made based on TB skin test and TB blood test.<unk>  susceptibility tests will show the<unk>  resistance pattern of that strain of bacteria. People who show the above mentioned symptoms, or who have been in contact with someone who has the disease, should seek medical attention. Treatment options will be based on the results of the<unk>  susceptibility test, and generally involve 4 or more<unk> s. Surveillance of treatment adherence is an important tool to ensure adequate therapy, thereby decreasing the chances of<unk>  resistance and/or relapse of the disease. There is a vaccine available (BCG), however it is not generally recommended in the United States due to its limited effectiveness in preventing TB overall. Complications of pulmonary TB may include permanent lung damage, liver damage and eye problems.
Multi-drug-resistant tuberculosis
Extensively drug-resistant tuberculosis
Tuberculosis
Miliary tuberculosis
Invasive aspergillosis
HIV coinfection with tuberculosis
BCGosis
Sarcoidosis